Juan Pablo Rojas Manrique· @JPRojasUroOnco · X·· 22 小时前评分70
正文 · 原文
At #ESMO26, Alberto Briganti presented the PROTEUS substudy, reporting improved EFS with perioperative apalutamide + ADT (HR 0.38).
Nicholas van As discussed key limitations and concluded that longer follow-up is needed before changing clinical practice.
#ProstateCancer
34 浏览 · 1 赞 · 0 转发 · 0 回复
来源：Juan Pablo Rojas Manrique · x.com